±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 4617  |  »Ø¸´: 69
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û60´Î£¬×÷Õßzhuimengren639Ôö¼Ó½ð±Ò 56.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

[×ÊÔ´] ·ÖÏí£ºµÂ¹úº£µÂ±¤´óѧHugo Kubinyi½ÌÊÚµÄÒ©ÎïÉè¼ÆµÄ¿Î¼þ

µÂ¹úUniversity of HeidelbergµÄÖøÃûÒ©Îﻯѧ¼ÒHugo Kubinyi¹ØÓÚÒ©ÎïÉè¼ÆµÄ¿Î¼þ£¬ÏàÐŶԸãÒ©ÎïÉè¼ÆµÄͬѧ»áÓÐÓõġ£

Èç¹û¸Ð¾õµ¥¸öÏÂÔØÌ«Âé·³£¬ÄÇô¿ÉÒÔÓà flashget/ѸÀ×ÅúÁ¿ÏÂÔØ£¬Ï£Íû´ó¼ÒÄܹ»Ï²»¶£¬Ó»Ô¾ÆÀÂÛ£¡

¿´µ½ÓÐÕâô¶à³æÓÑϲ»¶Õâ¸ö¿Î¼þ£¬ÎªÁ˸Ðл´ó¼Ò£¬ÎÒ°ÑÎÒÏÂÔØµÄ´«µ½ÄÉÃ×ÅÌÉϹ©´ó¼ÒÏÂÔØ£¬µØÖ·ÈçÏÂ
http://www.namipan.com/d/Hugo%20 ... c4504bad9361a9db300


ÄÚÈÝ:

Drug Discovery (758 kBlack Eye
http://www.kubinyi.de/dd-01.pdf

Serendipity and Rational Design (374 kBlack Eye
http://www.kubinyi.de/dd-02.pdf

Chemogenomics (1,453 kBlack Eye
http://www.kubinyi.de/dd-03.pdf

Ligand-Receptor Interactions (647 kBlack Eye
http://www.kubinyi.de/dd-04.pdf

Hydrogen Bonds and Biological Activities (359 kBlack Eye
http://www.kubinyi.de/dd-05.pdf

Chemical Similarity and Biological Activities (686 kBlack Eye
http://www.kubinyi.de/dd-06.pdf

Drug Metabolism (501 kBlack Eye
http://www.kubinyi.de/dd-07.pdf

Peptidomimetics and Prodrugs (294 kBlack Eye
http://www.kubinyi.de/dd-08.pdf

Combinatorial Chemistry Technology (147 kBlack Eye
http://www.kubinyi.de/dd-09.pdf

Combinatorial Chemistry in Drug Research (215 kBlack Eye
http://www.kubinyi.de/dd-10.pdf

QSAR Parameters (284 kBlack Eye
http://www.kubinyi.de/dd-11.pdf

QSAR - Hansch and Free Wilson Analyses (153 kBlack Eye
http://www.kubinyi.de/dd-12.pdf

Variable Selection and Model Validation (935 kBlack Eye
http://www.kubinyi.de/dd-13.pdf

Nonlinear QSAR and 3D QSAR (173 kBlack Eye
http://www.kubinyi.de/dd-14.pdf

QSAR Examples (138 kBlack Eye
http://www.kubinyi.de/dd-15.pdf

Structure-Based Ligand Design (782 kBlack Eye
http://www.kubinyi.de/dd-16.pdf

Computer-Aided Ligand Design (850 kBlack Eye
http://www.kubinyi.de/dd-17.pdf

Pharmacophore Analyses (486 kBlack Eye
http://www.kubinyi.de/dd-18.pdf

Virtual Screening (299 kBlack Eye
http://www.kubinyi.de/dd-19.pdf

Combinatorial and Fragment-Based Ligand Design (945 kBlack Eye
http://www.kubinyi.de/dd-20.pdf

Serine Proteases and their Inhibitors (371 kBlack Eye
http://www.kubinyi.de/dd-21.pdf

Thrombin Inhibitor Design (332 kBlack Eye
http://www.kubinyi.de/dd-22.pdf

Problems in Drug Design (1,043 kBlack Eye
http://www.kubinyi.de/dd-23.pdf

In Search for New Leads
http://www.kubinyi.de/paris-07-05.pdf

From Leads to Drugs
http://www.kubinyi.de/wien-06-05.pdf

Validation and Predictivity of QSAR Models
http://www.kubinyi.de/istanbul-2004-lecture.pdf

[ Last edited by zhuimengren639 on 2008-10-25 at 22:39 ]
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

¸öÈËËѼ¯¾«»ª

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÙÚ½¨²¨

ľ³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

лл£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡
21Â¥2008-10-25 21:52:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 70 ¸ö»Ø´ð

xufund

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

very good
thanks
2Â¥2008-10-24 21:09:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gp0713

Òø³æ (СÓÐÃûÆø)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

very good£¡thanks£¡
3Â¥2008-10-24 21:59:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lijianyong

½ð³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ºÃµÄºÜ°¡
лл
ÓйØÒ©ÎïÉè¼Æ¶¼»¶Ó­
5Â¥2008-10-25 03:15:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
2008-10-24 22:03   »Ø¸´  
 
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +6 ÉîVËÞÉá°É 2026-03-29 6/300 2026-03-29 20:51 by ÌÆãå¶ù
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬335·Ö£¬0856£¬Çóµ÷¼ÁԺУºÍµ¼Ê¦ +5 Çã____Ïô 2026-03-27 6/300 2026-03-29 16:35 by ÌÆãå¶ù
[¿¼ÑÐ] Çóµ÷¼Á +9 ÕÅzz111 2026-03-27 10/500 2026-03-29 14:57 by ÌÆãå¶ù
[¿¼ÑÐ] 327Çóµ÷¼Á +6 ¼³Òàê» 2026-03-29 6/300 2026-03-29 13:40 by peike
[¿¼ÑÐ] 349Çóµ÷¼Á +6 Àîľ×Ó°¡¹þ¹þ 2026-03-25 6/300 2026-03-29 12:47 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 312£¬ÉúÎïѧÇóµ÷¼Á +3 СÒëͬѧabc 2026-03-28 3/150 2026-03-28 15:32 by ÂäÉ˼
[¿¼ÑÐ] ²ÄÁÏ277Çóµ÷¼Á +7 min3 2026-03-24 7/350 2026-03-28 11:39 by xuxiang
[¿¼ÑÐ] 340Çóµ÷¼Á +5 jhx777 2026-03-27 5/250 2026-03-28 04:18 by fmesaito
[¿¼ÑÐ] 279 ·Ö Çóµ÷¼Á +4 ˯¸öºÃ¾õ_16 2026-03-24 4/200 2026-03-27 15:05 by ×íÔÚ·çÀï
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ÇóÇóÁËÊÕÏÂÎÒ°É£ 2026-03-26 4/200 2026-03-27 10:37 by zhshch
[¿¼ÑÐ] Ò»Ö¾Ô¸Ìì½ò´óѧ339²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +3 ½­ÍùÂôÓã 2026-03-26 3/150 2026-03-26 09:42 by ÍõСǷi
[¿¼ÑÐ] ¡¾2026¿¼Ñе÷¼Á¡¿ÖÆÒ©¹¤³Ì 284·Ö ÇóÏà¹Ø×¨Òµµ÷¼ÁÃû¶î +4 Ô¬Û¼Û¼ 2026-03-25 8/400 2026-03-25 14:32 by lbsjt
[¿¼ÑÐ] 282Çóµ÷¼Á +3 wcq131415 2026-03-24 3/150 2026-03-25 12:16 by userper
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +3 iwinso 2026-03-23 3/150 2026-03-25 11:29 by greychen00
[¿¼ÑÐ] ÉϺ£µçÁ¦´óѧ²ÄÁÏ·À»¤ÓëвÄÁÏÖØµãʵÑéÊÒÕÐÊÕµ÷¼ÁÑо¿Éú£¨²ÄÁÏ¡¢»¯Ñ§¡¢µç»¯Ñ§£¬»·¾³£© +4 ÎÒ°®Ñ§µç³Ø 2026-03-23 4/200 2026-03-25 00:59 by 1027_324
[Óлú½»Á÷] ÓлúºÏ³ÉÇóÖú 20+3 FENGSHUJEI 2026-03-23 5/250 2026-03-24 19:31 by 88817753
[¿¼ÑÐ] ²ÄÁÏר˶ÕÒµ÷¼Á +5 ¹þ¹þ¹þºðºðºð¹þ 2026-03-23 5/250 2026-03-24 19:07 by ÁËÁËÁËÁË¡£¡£
[¿¼ÑÐ] Ò»Ö¾Ô¸¹ú¿Æ¹ý³ÌËù081700£¬274Çóµ÷¼Á +3 ÈýË®ÑÐ0Ë®Á¢·½ 2026-03-23 3/150 2026-03-23 23:11 by MajorWen
[¿¼ÑÐ] 269Çóµ÷¼Á +4 ÎÒÏë¶ÁÑÐ11 2026-03-23 4/200 2026-03-23 21:25 by pswait
[¿¼ÑÐ] 336»¯¹¤µ÷¼Á +4 Íõ´ó̹1 2026-03-23 5/250 2026-03-23 18:32 by allen-yin
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û